Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 103 results for "ramanathan k"

BIND-014 Nanoparticle in Solid Tumors

Daniel D. Von Hoff 1 , Monica M. Mita 2 , Ramesh K. Ramanathan 3 , Glen J. Weiss 4 , Alain C. Mita 2 , Patricia M. LoRusso 5 , Howard A. Burris III 6 , Lowell L. Hart 7 , Susan C. Low 8 , Donald M. Parsons 8 , Stephen E. Zale 8 , Jason M. Clinical Cancer Research, 3 weeks ago

THANJAVUR

As many as 146 candidates are in the fray for the nine assembly constituencies in Tiruchi district, after the deadline for withdrawal of nominations ended on Monday. Six candidates withdrew their nominations on Monday. With 21 candidates in the ...
 The Hindu1 day ago 22 candidates file nomination papers in Thanjavur district  The Hindu6 days ago
TheStar.com.my

United colours of Malaysian cinema

OLA Bola proves that multiculturalism sells. People actually watch a film with a multi-racial theme. There is a crying need for truly Malaysian films. Popular culture transcends race. If all else fails to unite us, hopefully popular culture will.
 TheStar.com.my2 days ago

Panel to decide on final relief

HC appoints committee to study case of 16 patients who contracted Hepatitis C at govt. hospital The Madras High Court on Friday appointed a one-judge committee to determine the final compensation that can be awarded to the 16 patients who had ...
 The Hindu3 days ago

Panel to decide on final compensation

HC appoints committee to study case of 16 patients who contracted Hepatitis C at govt. hospital The Madras High Court on Friday appointed a one-judge committee to determine the final compensation that can be awarded to the 16 patients who had ...
 The Hindu4 days ago

BERG Initiates Phase II Combination Trial Of BPM 31510 And Gemcitabine In Patients With Pancreatic Cancer

/PRNewswire/ --BERG, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, today announced that it has initiated a Phase II clinical trial for its drug candidate BPM 31510 in combination with ...
 Sys-Con Canada1 week ago
[x]  
Deccan Chronicle

T Nagar residents talk to MK Stalin

Chennai: Distressed T Nagar residents, who have decided to opt for Nota in the upcoming Assembly elections, on Thursday briefed DMK leader M.K. Stalin about the perennial issues in the constituency that have remained unsolved for more than a decade.
 Deccan Chronicle5 days ago
New Indian Express

Farmer-centric Congress Manifesto Promises Right to Service Act

CHENNAI: Numerous promises for farmers, educated youth, industrial growth, enforcement of total prohibition, enactment of Right to Service Act to ensure time-bound grievance redressal for public, administrative reforms and importance to local bodies ...
 New Indian Express6 days ago

UK's ECCC backs fifth carbon budget proposal to cut emissions by 57% from 1990

A House of Commons select committee backed the UK's proposal to set the fifth carbon budget at 1,765 million metric tons of carbon dioxide equivalent (MtCO2e), which would cut emissions to an average 57% below 1990 baseline levels. In a report on ...
 Platts1 week ago

Back to the days of Polo

The sport, which once ruled Madras, is making a comeback. A.C. Muthiah talks to on the game, then and now Industrialist A.C. Muthiah's first love, albeit for a brief while, was tennis. He trained under T.K. Ramanathan, Ramanathan Krishnan's ...
 The Hindu1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less